Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

AstraZeneca signs deals to increase anti-infective portfolio

January 7, 2010 Research and Development, Sales and Marketing AstraZeneca, Forest, Novexel

AstraZeneca is to buy infection research firm Novexel for $350 million. The manufacturer will take all the French company’s shares …
News
Woodley David

David Wood and Joanne Platt join Woodley Equipment

January 7, 2010 Research and Development appointment, research and development, woodley

Woodley Equipment has appointed David Wood medical electronics manager and Joanne Platt as customer service representative. David will be instrumental …
Appointment

Alcon directors protest Novartis takeover bid

January 6, 2010 Research and Development, Sales and Marketing Alcon, Novartis

An independent committee of directors of Alcon has expressed its disappointment with the recent takeover bid from Novartis, saying the …
News
JGerberding_cdc_photo

Dr Julie Gerberding appointed to head up Merck Vaccines

January 6, 2010 Research and Development, Sales and Marketing Merck, appoinment, research and development, sales and marketing, vaccines

Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …
Appointment
Witty

GSK’s Andrew Witty appointed president of EFPIA

January 5, 2010 Research and Development, Sales and Marketing Andrew Witty, EFPIA, GSK, appointment, research and development, sales and marketing

GlaxoSmithKline chief executive Andrew Witty has been appointed president of EFPIA.He previously served as vice-president of the European industry association for two years and takes …
Appointment

Strong growth predicted for pharma contract services

January 5, 2010 Manufacturing and Production, Research and Development contract research, industry, manufacturing and production

The market for contract services in the pharmaceutical sector has been pegged back since the end of 2008, but looks …
News
Roche's new Building 1

Roche plans striking new Basel offices

January 4, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Basel, Roche, construction

Roche has unveiled plans for its new main office building in Basel, Switzerland, that will accommodate more than 1,800 people …
News

Serge Weinberg joins board at Sanofi-Aventis

January 4, 2010 Research and Development, Sales and Marketing Sanofi-Aventis, appointment, research and development, sales and marketing

Serge Weinberg has joined the board of directors at Sanofi-Aventis, replacing Gunter Thielen, who has resigned for personal reasons. The …
Appointment

Cancer Research UK and Merck KGaA to co-develop leukaemia candidate

January 4, 2010 Research and Development Merck Serono, leukaemia, oncology

Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialisation arm, are to undertake a phase I …
News

Celgene

January 1, 2010 Research and Development, Sales and Marketing Abraxane, Celgene, Revlimid, Thalidomide

Founded in 1986, Celgene was created as a spin off from the Celanese Corporation. Two years later, the company received …
Feature

Pharma mergers and acquisitions in 2009

December 22, 2009 Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
Feature

Contract research news in brief

December 22, 2009 Research and Development AAIPharma, Benten BioServices, CRO, Covance, ICON, PharmaVigilant, Phase Forward, SynRG

Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …
News

Sanofi’s Plavix combination recommended for European approval

December 21, 2009 Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux

Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
News

Dr Michael Rosenblatt appointed chief medical officer Merck

December 21, 2009 Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing

Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …
Appointment
Merck & Co building

Merck buys Avecia to boost biomanufacturing

December 21, 2009 Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm

Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025